Tag: PBMs

Experts identified key actions health benefit plan sponsors should consider with respect to pharmacy benefit managers.

Lawmakers from both parties said pharmacy benefit managers and consultants who advise employers may be profiting from opaque arrangements that...

Groom Law Group lawyers say new reporting, participant access and $10,000-per-day penalties could reshape PBM contracting—and raise fiduciary scrutiny of...

The recent federal appropriations act, which ended a brief partial government shutdown, included pharmacy benefit manager reforms.

The new rule would force pharmacy benefit managers to reveal how—and how much—they get paid.

The proposal aims to curb prescription drug pricing, according to the bill’s sponsors.

Talent attraction and retention are no longer employers’ top strategic priorities, a new Brown & Brown study found.

Lack of standing again doomed the case that had been amended twice, but the plaintiffs were granted leave to amend it again. 

The ERISA Industry Committee and a plethora of employers, workers, patients, providers and consumers joined in seeking changes to pharmacy...

The ERISA Industry Committee praised the state legislature’s efforts to amend a proposal to prevent state oversight from clashing with...

In a recent study by Mercer, 77% of employers named the management of GLP-1 costs as their top health-benefit issue.

Experts discussed how pharmacy benefit managers drive the cost of prescription drugs and what plan sponsors should watch for in...

The executive order signed on Wednesday requires the Secretary of Labor to propose regulations to improve transparency into compensation of...

Accessing health plan data is a plan sponsor’s ‘superpower’ and provides leverage in negotiations with pharmacy benefit managers, according to...

Financial Finesse and SecureSave announce partnership;  Lincoln Financial expands solutions available in WellnessPATH Marketplace; Pharmacy benefits manager offers “Savings Guarantee,”...

The defendants claim the company breached its ERISA fiduciary duty by putting business interests ahead of the plan and its...

The Federal Trade Commission found that the big three PBMs have marked up the price of numerous specialty generic drugs,...

The Federal Trade Commission filed a lawsuit against the largest PBMs, following its July report exposing the ‘opaque’ business practices...

The ERISA Industry Committee argues that as fiduciaries, pharmacy benefit managers would be required to act participants’ best interest and...

The pharmacy benefit manager is accusing the Federal Trade Commission of illegally criticizing PBMs, which it holds responsible for inflating...